Sharp Therapeutics (TSXV:SHRX) Inventories, Raw Materials & Components: C$0.00 Mil (As of Dec. 2025)


TSXV:SHRX Sharp Therapeutics Corp TSXV:SHRX
15 GF Score
Price C$0.91
View Full Analysis

What is Sharp Therapeutics Inventories, Raw Materials & Components?

Sharp Therapeutics TSXV:SHRX 15 Inventories, Raw Materials & Components is C$0.00 Mil as of Dec. 2025. GuruFocus rates TSXV:SHRX with a GF Score™ of 15/100.

Sharp Therapeutics's inventories, raw materials & components for the quarter that ended in Dec. 2025 was C$0.00 Mil.

Sharp Therapeutics Inventories, Raw Materials & Components Historical Data

* Premium members only.

The historical data trend for Sharp Therapeutics's Inventories, Raw Materials & Components can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sharp Therapeutics Inventories, Raw Materials & Components Chart

Sharp Therapeutics Annual Data
Trend Dec23 Dec24 Dec25
Inventories, Raw Materials & Components
0.00 0.00 0.00

Sharp Therapeutics Quarterly Data
Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Inventories, Raw Materials & Components Get a 7-Day Free Trial Premium Member Only 0.00 0.00 0.00 0.00 0.00
TSXV:SHRX
15GF Score
Sharp Therapeutics Corp TSXV:SHRX
Inventories, Raw Materials & Components is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sharp Therapeutics Inventories, Raw Materials & Components Calculation

Materials and components scheduled for use in making a product.

What does a Inventories, Raw Materials & Components of C$0.00 Mil mean?
Sharp Therapeutics (TSXV:SHRX) has a Inventories, Raw Materials & Components of C$0.00 Mil as of Dec. 2025. Raw materials are the components a company uses for its main products. View historical data on Sharp Therapeutics and its competitors.
Is Sharp Therapeutics' Inventories, Raw Materials & Components too high?
Sharp Therapeutics' current Inventories, Raw Materials & Components is C$0.00 Mil. Overall, Sharp Therapeutics has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does Sharp Therapeutics' Inventories, Raw Materials & Components compare to VRTX and REGN?
Sharp Therapeutics' Inventories, Raw Materials & Components of C$0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Raw Materials & Components for a Biotechnology company?
A good Inventories, Raw Materials & Components depends on the Biotechnology industry context. However, Inventories, Raw Materials & Components should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Raw Materials & Components mean?
A high Inventories, Raw Materials & Components can signal that a stock is expensive relative to its fundamentals. Raw materials are the components a company uses for its main products. View historical data on Sharp Therapeutics and its competitors. Sharp Therapeutics's current Inventories, Raw Materials & Components is C$0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sharp Therapeutics stock overvalued right now?
Sharp Therapeutics (TSXV:SHRX) has a current Inventories, Raw Materials & Components of C$0.00 Mil. The current Inventories, Raw Materials & Components is C$0.00 Mil. Sharp Therapeutics' overall GF Score™ is 15/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Raw Materials & Components calculated?
Inventories, Raw Materials & Components is calculated from a company's financial statements. For Sharp Therapeutics (TSXV:SHRX), the current Inventories, Raw Materials & Components is C$0.00 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Sharp Therapeutics Business Description

Address 2403 Sidney Street, Suite 264, Pittsburgh, PA, USA, 15203
Sharp Therapeutics Corp is a preclinical-stage drug discovery company developing therapeutics for genetic diseases. It has developed the patent-protected Disco discovery platform consisting of the CoreX biology, AlloChem chemistry, and Mine computational technologies to discover drugs that selectively activate the protein thats been altered by gene mutation. The company has targeted its discovery engine (Disco) to three hereditary disorders with high unmet need, which include Gauchers Disease, Familial Frontotemporal Dementia, and Niemann Pick Type-C. Its drug development pipeline consists of the following candidates: SEL-148, 721, SEL-148, 742, and SEL-145, 793. Geographically, the company's business operations are carried out in the United States of America.
15GF Score

Get the complete analysis for TSXV:SHRX

Inventories, Raw Materials & Components is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

C$0.91
Price